BIORPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Biorphen, and what generic alternatives are available?
Biorphen is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in BIORPHEN is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Biorphen
A generic version of BIORPHEN was approved as phenylephrine hydrochloride by HIKMA on December 20th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BIORPHEN?
- What are the global sales for BIORPHEN?
- What is Average Wholesale Price for BIORPHEN?
Summary for BIORPHEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Drug Prices: | Drug price information for BIORPHEN |
| What excipients (inactive ingredients) are in BIORPHEN? | BIORPHEN excipients list |
| DailyMed Link: | BIORPHEN at DailyMed |
Pharmacology for BIORPHEN
| Drug Class | alpha-1 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha1-Agonists |
US Patents and Regulatory Information for BIORPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | BIORPHEN | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 212909-001 | Oct 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Sa | BIORPHEN | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 212909-002 | Mar 11, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
